Wound healing composition with amino acids and fish collagen
Summary
The USPTO has published a new patent application detailing a composition for promoting wound healing. The composition includes an amino acid mixture and fish collagen, with a method for its administration also described. This application was filed on September 20, 2024.
What changed
This document is a patent application (US20260083825A1) filed with the USPTO, describing a novel composition for promoting wound healing. The composition comprises a specific weight ratio of an amino acid mixture (including glycine and proline) and fish collagen. A method for administering this composition to promote wound healing is also detailed.
This patent application does not impose immediate regulatory obligations on companies. However, it signifies potential future intellectual property and market exclusivity for the inventors in the therapeutic wound care sector. Companies operating in this space should monitor the patent's progress and consider its implications for their own product development and market strategies.
Archived snapshot
Mar 27, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COMPOSITION FOR PROMOTING WOUND HEALING AND METHOD FOR PROMOTING WOUND HEALING USING THE SAME
Application US20260083825A1 Kind: A1 Mar 26, 2026
Inventors
Yu-Pu Chu, Yi-Meng Chang
Abstract
A composition for promoting wound healing includes an amino acid mixture and a fish collagen present in a weight ratio ranging from 1:3 to 3:1. The amino acid mixture includes glycine and proline. A method for promoting wound healing which includes administering to a subject in need thereof the composition is also provided.
CPC Classifications
A61K 38/39 A61K 31/198 A61P 17/02
Filing Date
2024-09-20
Application No.
18892124
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.